johnson & johnson - Search News

Johnson & Johnson Q4 Profit Decreases

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

Business Insider · 21h

Johnson & Johnson Q4 Profit Decreases, But Beats Estimates

Johnson & Johnson (JNJ) announced a profit for fourth quarter that decreased from last year but beat the Street estimates. The

AOL · 18h

Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings

Johnson & Johnson beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highligh

Zacks.com on MSN · 21h

Johnson & Johnson (JNJ) Q4 Earnings and Revenues Top Estimates

Johnson & Johnson (JNJ) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $2.29 per share a year ago. These figures are adjusted for non-recurring items.

FDA approves Johnson & Johnson’s nasal spray for depression

Fortune on MSN · 8h

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult population.

U.S. News & World Report · 16h

FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral antidepressants,

Popular Science · 17h

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

Bears officially announce Ben Johnson

Chicago Tribune on MSN · 7h

Brad Biggs: Guided by self-awareness, Ben Johnson is finally prepared for his role as head coach of the Bears

Ben Johnson launched into his virtual interview with the Chicago Bears leaving no question as to his intentions. “I want this job,” Johnson said, Chairman George McCaskey recalled. The feeling was mutual and the Bears agreed to terms with Johnson on Monday.

USA TODAY Sports on MSN · 14h

Chicago Bears' Ben Johnson becomes one of youngest head coaches in NFL. See where he ranks

The Bears introduce Ben Johnson as new head coach, continuing a trend started with Sean McVay. Johnson isn't the youngest in the NFL, but he's close.

The Washington Post · 1d

With Ben Johnson on the move to Chicago, 5 head coaching vacancies remain

Ben Johnson made a quick decision. Aaron Glenn could be next. With Johnson heading to Chicago and Mike Vrabel already in New England, five head coaching vacancies remain. The Jets, Saints, Jaguars, Raiders and Cowboys are still in the hunt.

6hon MSN

Ben Johnson's goal: Tearing down Caleb Williams and building him back up

The fix is in for Caleb Williams, and it's going to be done for the Bears' second-year QB by his new head coach.

19h

Johnson & Johnson says positioned for 5%-7% growth through 2030 and beyond

Says starting 2025 from a position of strength. Says invested ~$50B in R&D and M&A in 2024. Says continues to invest in R&D at ...

MassDevice21h

Johnson & Johnson MedTech sales grow 6.2% in 2025, driven by EP, Abiomed

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...

16hon MSN

Johnson & Johnson clears a few hurdles, but Wall Street focuses on weak guidance

Johnson & Johnson’s stock dropped more than 3% Wednesday after the medical-technology and drug company beat estimates for the fourth quarter but as lower sales guidance for the year stoked fears of ...

18h

Bronstein, Gewirtz & Grossman, LLC Encourages Johnson & Johnson (JNJ) Shareholders to Inquire about Securities Investigation

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Johnson & Johnson has secured FDA approval for expanded use of its Spravato nasal spray, now cleared as a standalone ...

TipRanks on MSN3d

Johnson & Johnson’s New Acquisition Could Result in Tremendous Rewards

Staying ahead of the competition is critical in every sector, particularly in the dynamic healthcare space, where a single ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Johnson & Johnson Q4 Profit Decreases

FDA approves Johnson & Johnson’s nasal spray for depression

Bears officially announce Ben Johnson

Related topics